Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy Academic Article uri icon

Overview

MeSH Major

  • Body Mass Index
  • Carcinoma
  • Prostatectomy
  • Prostatic Neoplasms

abstract

  • Although conflicting evidence has been reported regarding the link between obesity and an increased risk of developing prostate carcinoma, as well as an increased risk of developing aggressive disease and prostate carcinoma-related mortality, the authors found weak associations with disease progression for both BMI and INVBMI. These variables were of negligible prognostic value in men who received surgery. Studies with longer follow-up, that examine alternative end points, and that follow treatment(s) besides surgery are needed.

publication date

  • May 15, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC1852497

Digital Object Identifier (DOI)

  • 10.1002/cncr.20991

PubMed ID

  • 15822118

Additional Document Info

start page

  • 2030

end page

  • 4

volume

  • 103

number

  • 10